In-Stent Restenosis after Femoropopliteal Interventions with Drug-Eluting Stents Same but Different?

JACC: Cardiovascular Interventions

Volumn 9, Issue 8, 2016, Pages 835-837

  Sobieszczyk, Piotr ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

in stent restenosis; peripheral artery disease; superficial femoral artery stenosis

Indexed keywords

CILOSTAZOL;

ATHERECTOMY; BARE METAL STENT; BRACHYTHERAPY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DOPPLER ULTRASONOGRAPHY; DRUG ELUTING CARDIOVASCULAR STENT; DRUG ELUTING NITINOL STENT; ENDOVASCULAR SURGERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MULTICENTER STUDY (TOPIC); NOTE; PACLITAXEL ELUTING CORONARY STENT; PEAK SYSTOLIC VELOCITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; RISK REDUCTION; SELF EXPANDING STENT; SIROLIMUS ELUTING CORONARY STENT; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY STENT; DRUG ELUTING STENT; FEMORAL ARTERY; RECURRENT DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TREATMENT OUTCOME;

CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; RECURRENCE; STENTS; TREATMENT OUTCOME;

EID: 84963864490     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.02.015     Document Type: Editorial

References (17)

1. J.S. Matsumura, D. Yamanouchi, J.A. Goldstein, and et al. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II) J Vasc Surg 58 2013 73 83.e1
2. H. Krankenberg, M. Schluter, H.J. Steinkamp, and et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
3. M. Schillinger, S. Sabeti, C. Loewe, and et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
4. J.R. Laird, A. Jain, T. Zeller, and et al. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial J Endovasc Ther 21 2014 202 212
5. W.A. Gray, A. Feiring, M. Cioppi, and et al. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes J Vasc Interv Radiol 26 2015 21 28
6. J.R. Laird, B.T. Katzen, D. Scheinert, and et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
7. S.H. Duda, M. Bosiers, J. Lammer, and et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 2006 701 710
8. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
9. M.D. Dake, D. Scheinert, G. Tepe, and et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study J Endovasc Ther 18 2011 613 623
10. M.D. Dake, G.M. Ansel, M.R. Jaff, and et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies J Am Coll Cardiol 61 2013 2417 2427
11. O. Iida, M. Takahara, Y. Soga, and et al. 1-Year results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): predictors of restenosis J Am Coll Cardiol Intv 8 2015 1105 1112
12. O. Iida, M. Takahara, Y. Soga, and et al. The characteristics of in-stent restenosis after drug-eluting stent implantation in femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy for these lesions J Am Coll Cardiol Intv 9 2016 828 834
13. E.J. Armstrong, S. Singh, G.D. Singh, and et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention Catheter Cardiovasc Interv 82 2013 1168 1174
14. O. Iida, S. Nanto, M. Uematsu, T. Morozumi, M. Kitakaze, and S. Nagata Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions J Vasc Surg 48 2008 144 149
15. T. Ohki, H. Yokoi, K. Kichikawa, and et al. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials J Endovasc Ther 21 2014 644 653
16. M.P. Bonaca, B.M. Scirica, M.A. Creager, and et al. Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50 Circulation 127 2013 1522 1529 1529.e1-6
17. G. Pavic, M. Grandoch, S. Dangwal, and et al. Thrombin receptor protease-activated receptor 4 is a key regulator of exaggerated intimal thickening in diabetes mellitus Circulation 130 2014 1700 1711